artificial aortocaval fistula (for 105 days)

 controlled sodium chloride content diet (8 %) (for 42 days) then streptozotocin (60 mg/kg) then insulin (10 ul) (for 42 days)

 left anterior descending coronary artery occlusion (for 224 days) then furosemide (10 mg/kg/d) (for 161 days) then ramipril (1 mg/kg/d) (for 182 days)

 control condition (for 91 days)

 controlled NG-nitroarginine methyl ester content drinking water (5 mg/kg/d) (for 42 days)

 artificial aortocaval fistula (for 28 days)

 controlled sodium content diet (0.3 %) (for 91 days)

 controlled sodium chloride content diet (0.3 %) (for 21 days) then controlled sodium chloride content diet (8 %) (for 42 days)

 standard diet

 controlled sodium content diet (8 %) (for 42 days) then 0.9% sodium chloride solution (0.3 ml) (for 42 days)

 sham surgical control condition (for 196 days)

 controlled sodium content diet (8 %) (for 28 days)

 controlled sodium content diet (0.3 %) (for 42 days) then controlled sodium content diet (8 %) (for 84 days)

 anti-rh-VEGF165 monoclonal antibody (1 mg) (for 42 days)

 controlled resveratrol content drinking water (1 mg/kg/d) (for 56 days)

 sham surgical control condition (for 224 days)

 left anterior descending coronary artery occlusion (for 224 days) then furosemide (10 mg/kg/d) (for 161 days)

 controlled sodium content diet (0.3 %) (for 42 days) then controlled sodium content diet (8 %) (for 42 days)

 controlled sodium chloride content diet (8 %) (for 42 days)

 left anterior descending coronary artery occlusion (for 196 days) then furosemide (10 ml/kg/d) (for 182 days)

 controlled sodium content diet (0.3 %) (for 42 days)

 controlled sodium content diet (8 %) (for 42 days) then cilazapril (10 mg/kg/d) (for 42 days)

 control IgG monoclonal antibody (1 mg) (for 42 days)

 controlled sodium chloride content diet (0.65 %) (for 98 days) then streptozotocin (60 mg/kg) then insulin (10 ul) (for 42 days)

 left anterior descending coronary artery occlusion (for 140 days)

 control condition

 sham surgical control condition (for 28 days)

 control condition (for 84 days)

 controlled sodium content diet (8 %) (for 42 days) then candesartan (1 mg/kg/d) (for 42 days)

 controlled ethanol content drinking water used as vehicle (1 %) (for 56 days)

 left anterior descending coronary artery occlusion (for 196 days) then vehicle control condition (for 182 days)

 Omacor (400 mg/kg/d) (for 56 days)

 left anterior descending coronary artery occlusion (for 28 days)

 sham surgical control condition (for 105 days)

 sham surgical control condition (for 140 days)

 controlled sodium chloride content diet (0.65 %) (for 98 days)